Omicron News and Research

RSS

Impact of rapid and comprehensive RT-qPCR for detecting SARS-CoV-2 variants of concern

Researchers reported the development and validation of a two-reaction multiplex reverse transcription-quantitative polymerase chain reaction genotyping strategy that distinguishes SARS-CoV-2 variants of concern.

14 Feb 2022

Study analyzes antigenic properties of SARS-CoV-2 Omicron sublineages

A new study elucidated the antigenic properties of the sublineages of the severe acute respiratory syndrome coronavirus-2 Omicron variant.

14 Feb 2022

Researchers identify a powerful combination of antivirals to treat COVID-19

Researchers at the University of Maryland School of Medicine and University of Pennsylvania Perelman School of Medicine have identified a powerful combination of antivirals to treat COVID-19.

14 Feb 2022

3 doses of Pfizer–Biontech COVID-19 vaccine offer more benefits than 2 doses

A Kaiser Permanente study published Feb. 14, 2022, in The Lancet Regional Health – Americas found that one month after a third dose, the Pfizer-BioNTech COVID-19 vaccine effectiveness is higher for preventing infection and hospitalization than 2 doses of the vaccine after 1 month.

14 Feb 2022

Differences in infection with Omicron or Delta SARS-CoV-2 variants among vaccinated population from the UK

In a recent study, researchers demonstrated that COVID-19 symptoms varied between cases of SARS-CoV-2 Omicron and Delta variants of concern.

14 Feb 2022

Covid precautions are part of Hispanic community’s efforts to tend to community good

On a snowy January morning, Luis Portillo stood in line on the side of a busy road in Silver Spring, Maryland — a suburb just north of Washington, D.C. — with about 200 other people, waiting for his turn to get tested for covid-19 at Mary's Center, a federally qualified health center.

14 Feb 2022

How a third booster BNT162b2 dose impacts anti-spike antibody levels

A new study aimed to investigate the mechanism by which the third booster BNT162b2 dose impacts anti-S levels.

14 Feb 2022

mRNA-1273 and mRNA-1273.529 Omicron-specific boosters highly effective in mouse model

In a study posted to the bioRxiv* preprint server, a team of researchers from the United States evaluated the protective effect of the preclinical version of the current Moderna Omicron-targeted mRNA-1273.529 vaccine against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) B.1.1.529 Omicron infection in mice.

14 Feb 2022

Study provides evidence for spike protein-independent attenuation of SARS-CoV-2 Omicron variant

A new study provided the structural basis for a robust interaction between the receptor-binding domain of the SARS-CoV-2 Omicron spike protein and mouse ACE2.

13 Feb 2022

CDC study first to show waning immunity after third dose of mRNA COVID-19 vaccine

A nationwide study from the U.S. Centers for Disease Control and Prevention is the first to show that immunity against severe COVID-19 disease begins to wane 4 months after receipt of the third dose of an mRNA vaccine (Pfizer or Moderna).

12 Feb 2022

Performance of SARS-CoV-2 antibodies improves only after previous infection, not vaccination

New research to be presented at this year's European Congress of Clinical Microbiology & Infectious Diseases (ECCMID 2022, Lisbon, 23-26 April) shows that, although over time the number of SARS-CoV-2 antibodies falls in both previously infected and vaccinated patients, the performance of antibodies improves only after previous infection (and not vaccination).

11 Feb 2022

New insights into the effects of COVID-19 vaccination on dialysis patients

Two studies in CJASN offer a better understanding of the effects of COVID-19 vaccination on individuals with kidney failure who are undergoing long-term dialysis.

11 Feb 2022

Model shows booster doses and antiviral pills may enable relaxation of SARS-CoV-2 social distancing

Researchers suggest that social distancing could be relaxed in order to reduce the number of severe cases of COVID-19, rather than stop the transmission of the SARS-CoV-2.

11 Feb 2022

What are taxpayers spending for those ‘free’ covid tests? The government won’t say.

The four free covid-19 rapid tests President Joe Biden promised in December for every American household have begun arriving in earnest in mailboxes and on doorsteps.

11 Feb 2022

Study investigates population immunity to SARS-CoV-2 through heterogenous pathways

A new study demonstrates COVID-19 vaccine-specific differences in the antibody responses and memory B-cell immunity in a sample population comprising of 197 vaccinated individuals in Mexico.

11 Feb 2022

Unavailability of COVID-19 testing linked to greater intentions to engage in risky behavior

A research survey of more than 1,100 people in the United States found that when COVID-19 testing wasn't available in their community, participants showed significantly greater intentions to engage in risky behavior, possibly leading to increased transmission of the virus.

10 Feb 2022

Omicron News and Research

Impact of rapid and comprehensive RT-qPCR for detecting SARS-CoV-2 variants of concern

Study analyzes antigenic properties of SARS-CoV-2 Omicron sublineages

Researchers identify a powerful combination of antivirals to treat COVID-19

3 doses of Pfizer–Biontech COVID-19 vaccine offer more benefits than 2 doses

Differences in infection with Omicron or Delta SARS-CoV-2 variants among vaccinated population from the UK

Covid precautions are part of Hispanic community’s efforts to tend to community good

How a third booster BNT162b2 dose impacts anti-spike antibody levels

mRNA-1273 and mRNA-1273.529 Omicron-specific boosters highly effective in mouse model

Study provides evidence for spike protein-independent attenuation of SARS-CoV-2 Omicron variant

CDC study first to show waning immunity after third dose of mRNA COVID-19 vaccine

Performance of SARS-CoV-2 antibodies improves only after previous infection, not vaccination

New insights into the effects of COVID-19 vaccination on dialysis patients

Model shows booster doses and antiviral pills may enable relaxation of SARS-CoV-2 social distancing

What are taxpayers spending for those ‘free’ covid tests? The government won’t say.

Study investigates population immunity to SARS-CoV-2 through heterogenous pathways

Unavailability of COVID-19 testing linked to greater intentions to engage in risky behavior

Study suggests SARS-CoV-2 Omicron showed increased household transmission and immune evasion in Norway

Spillover of SARS-CoV-2 Omicron variant infection in white-tailed deer in New York

Clinical severity of COVID-19 caused by SARS-CoV-2 variants and the effectiveness of mRNA vaccines against them

Neutralizing antibody ABP-310 found to be highly potent against SARS-CoV-2 variants including Omicron

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News